Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001628280-25-005480·CUMBERLAND PHARMACEUTICALS INC
Schedule 13G ownership disclosure
Cumberland Pharmaceuticals, Inc.
Common stock · CUSIP: 230770109
Event date: 2025-02-13
- Filing-level shares
- 5,702,296.00
- Percent of class
- 40.8%
- A.J. Kazimi
Shares: 5,702,296.00 · Class: 40.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001628280-25-005480
- Form type
- SCHEDULE 13G
- Filer
- CUMBERLAND PHARMACEUTICALS INC
- CIK
- CIK 1087294
- Filed
- Feb 13, 2025
- Reporting period
- Feb 13, 2025
- Description
- Schedule 13G beneficial ownership